seed
Stage
1
Investors
About
General Bio programs edible microbes to manufacture complex peptide therapeutics at a fraction of the current cost, focusing on oral delivery of drugs such as GLP-1 peptides using genetically engineered microbes as both production and delivery systems.
Explore General Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.